跳至主要内容
临床试验/ISRCTN11565460
ISRCTN11565460已完成2 期

Interreg diabetes centre for personalised medicine - unscheduled care in diabetes - study 2: inpatient study

niversity of the Highlands and Islands0 个研究点目标入组 60 人开始时间: 2021年11月10日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

2021 Results article in https://doi.org/10.1111/dme.14753 (added 10/05/2022)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • •Phase 2, Part B: pilot study – use of Flash Glucose Monitoring:
  • •1. Adults (aged 18 years and older)
  • •2. Diagnosed with diabetes
  • •3. Admitted to hospital wards defined in phase 1
  • •4. Able to read and understand the participant information sheet (PIS)
  • •5. Able to give written informed consent
  • •Phase 2, Part C: pilot study - evaluation interviews:
  • •1. Patients or HCPs that have participated in phase 2, part B
  • •2. Able to read and understand the participant information sheet (PIS)
  • •3. Able to give written informed consent

排除标准

  • •Phase 2, Part B: pilot study - use of flash glucose monitoring:
  • •1. Children or young people (aged younger than 18 years)
  • •2. Not diagnosed with diabetes
  • •3. Admitted to hospital wards not defined in phase 1
  • •4. Pregnancy or gestational diabetes
  • •5. Significant intercurrent illness and/or terminal diagnosis
  • •6. Have a condition and/or treatment known to affect variability of blood glucose, such as on kidney dialysis
  • •7. Already using a Flash Glucose Monitoring or continuous monitoring device
  • •8. Unable to read and understand the participant information sheet (PIS)
  • •9. Unable to give written informed consent
  • •Phase 2, Part C: pilot study - evaluation interviews:
  • •1. Ongoing significant co-morbid illness
  • •2. Unable to read and understand the participant information sheet

研究者

发起方
niversity of the Highlands and Islands

相似试验